Leukemia inhibitory factor enhances regeneration in skeletal muscles after myoblast transplantation

Jason D. White, John J. Bower, John B. Kurek, Lawrie Austin

    Research output: Contribution to journalArticle

    26 Citations (Scopus)

    Abstract

    Cell-based therapies, such as myoblast transfer therapy, are likely to become an integral part of any approach to treat myopathies such as Duchenne muscular dystrophy. Previous studies have shown that an increased level of regeneration in the host muscle enhances incorporation of donor myoblasts. Leukemia inhibitory factor (LIF) increases the number of dystrophic fibers expressing dystrophin after myoblast transplantation and enhances regeneration in injured and diseased muscle. Morphometric analysis was used to investigate whether an increased level of regeneration is induced by LIF after myoblast transplantation, We found that, in muscles treated with LIF, the number of fibers undergoing regeneration was increased. The increased incorporation of donor myoblasts and thus dystrophin expression induced by LIF may be due, at least in part, to an increased level of regeneration of dystrophic muscle.
    Original languageEnglish
    Pages (from-to)695-697
    Number of pages3
    JournalMuscle and Nerve
    Volume24
    Issue number5
    DOIs
    Publication statusPublished - 07 May 2001

    Fingerprint Dive into the research topics of 'Leukemia inhibitory factor enhances regeneration in skeletal muscles after myoblast transplantation'. Together they form a unique fingerprint.

    Cite this